PubMed Health⌕ Search

Biomedical subjects

Tom Palmstierna

Publications and source records attributed to Tom Palmstierna.

6 recordsLinked to original sources

Evaluation of the Perception of Aggression Scale (POAS) in Swedish nurses.

Even though much is known about individual risk factors for institutional violence, large variations in frequency between institutions still remain unexplained. Staff attitudes have been pointed out as a possible important and explaining factor. The Perception of Aggression Scale (POAS) is a newly developed attitude inventory assessing nurses' attitudes toward aggressive patients. The aims of this study are to evaluate the factor structure of the Swedish version of the POAS and to evaluate its discriminatory capacity in different groups of nurses. The shortened POAS was handed out to 357 nurses at 12 different psychiatric wards in Sweden. Responses were analysed with exploratory principal component factor analysis. The emerging factors were correlated in a rank-transformed multiple regression analysis to individual characteristics of each nurse. The factor analyses revealed exactly the same factor structure in this Swedish sample of nurses as in previous German and Dutch studies. When expanding the factor analysis, a three-factor solution emerged. It was also found that the factor "Aggression as a protective measure" was correlated to age and experience of aggression management training while the factor "Aggression as dysfunctional/undesirable phenomenon" was sensitive for gender. The shortened 12-item POAS contains three discrete dimensions and thus seems to be a solid tool for evaluating attitudes towards violence. Of special interest is the possibility that the factor "Aggression as a protective measure" could be sensitive to training. Further studies should correlate dimensions of staff attitudes to the occurrence of inpatient violence.

Adult↗

Length of outpatient addiction treatment and risk of rehospitalization.

Several studies, mainly from the U.S. and usually with selected male samples, show that aftercare is positively related to lower risk of re-addiction or re-treatment. The present study extends this line of research in a report from public health health care addiction treatment services in Stockholm County. The study sample comprises all 196 men and 100 women alcohol-dependent patients from 10 districts hospitalized for at least 2 days during 1997-99 and who received outpatient care within 5 days. These patients were followed up until 2000, without attrition for renewed rehospitalization. Greater length of outpatient treatment was significantly related to reduced rehospitalization, but only in men. The intensity (average number of visits) of outpatient treatment was not significantly related to rehospitalization. The different effect of length of outpatient treatment between the genders may be due to differences in severity of alcohol dependence, social situation, psychiatric co-morbidity, and/or the extent to which treatment met patients' needs.

Aftercare↗

Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample.

Psychometric properties of the 11-item self-report Drug Use Disorders Identification Test (DUDIT) were evaluated in a sample of heavy drug users from prison, probation, and inpatient detoxification settings, and in a general Swedish population sample. In the drug user sample, the DUDIT predicted drug dependence with a sensitivity of 90% for both DSM-4 and ICD-10 and a respective specificity of 78 and 88%. Reliability according to Cronbach's alpha coefficient was 0.80. In the population sample, 3.1% scored positive on the DUDIT; T-score values are suggested. The DUDIT screens effectively for drug-related problems in clinically selected groups and may prove useful in the context of public health surveys.

Adolescent↗

Effects of a high-dose fast tapering buprenorphine detoxification program on symptom relief and treatment retention.

A large number of patients with heroin dependency fail to enter a treatment program because of dropping out during or immediately after detoxification. This article presents an open study of symptom relief of 10 patients withdrawing from heroin with a high-dose rapid tapering buprenorphine detoxification protocol. It also presents a pseudo-experimental comparison between 208 patients treated with a clonidine/dextropropoxiphene detoxification protocol and 246 patients treated with the high-dose rapid tapering buprenorphine detoxification protocol to evaluate differences in patients' ability to continue in treatment of addiction immediately after detoxification. The results indicate that 24 mg of sublingually administered buprenorphine beginning when the patient judges himself to be in a withdrawal state followed by another three days of daily administered and rapidly decreased doses resulted in a significant reduction of withdrawal symptoms. Also, when the clonidine/dextropropoxiphene protocol was replaced with this buprenorphine protocol the number of patients continuing in treatment immediately after discharge from the detoxification ward increased from 41.3% to 58.1%. Buprenorphine given in high doses with rapid tapering when withdrawal symptoms occur seems to offer an effective symptom-alleviating treatment, probably also decreasing the number of drop-outs after detoxification.

Adult↗